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Biotin proximity tagging favours unfolded
proteins and enables the study of intrinsically
disordered regions
David-Paul Minde 1,3*, Manasa Ramakrishna 2,3 & Kathryn S. Lilley 1*
Intrinsically Disordered Regions (IDRs) are enriched in disease-linked proteins known to have
multiple post-translational modiﬁcations, but there is limited in vivo information about how
locally unfolded protein regions contribute to biological functions. We reasoned that IDRs
should be more accessible to targeted in vivo biotinylation than ordered protein regions, if
they retain their ﬂexibility in human cells. Indeed, we observed increased biotinylation density
in predicted IDRs in several cellular compartments >20,000 biotin sites from four proximity
proteomics studies. We show that in a biotin ‘painting’ time course experiment, biotinylation
events in Escherichia coli ribosomes progress from unfolded and exposed regions at 10 s, to
structured and less accessible regions after ﬁve minutes. We conclude that biotin proximity
tagging favours sites of local disorder in proteins and suggest the possibility of using biotin
painting as a method to gain unique insights into in vivo condition-dependent subcellular
plasticity of proteins.
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Cellular complexity often arises from structurally disorderedproteins1–4. Intrinsically disordered regions (IDRs) withinproteins often overlap with sites of alternative splicing and
post-translational modiﬁcations (PTMs). Both splicing and PTMs
together are estimated to expand the number of proteoforms into
the millions despite a relatively compact (~20,000 large) protein-
coding human genome5–7. Alternative splicing is frequent within
the IDRs of proteins and can be a crucial element of PTM reg-
ulation, for instance by removal, recombination or modiﬁed local
accessibility of potential sites of modiﬁcation3,8. Proteins rich
in IDRs, intrinsically disordered proteins (IDPs), are often
linked to diseases, such as cancer, neurodegeneration and heart
diseases9–14. Interest in understanding the role of IDPs is thus
increasing within the biomedical research community.
Despite increasing community interest, it has remained chal-
lenging to deﬁne the phenomenon of intrinsic disorder as clearly
as the ordered complement of the structural proteome. Rigidly
folded proteins can be solved in high-resolution crystal, cryo-EM
or NMR structures that can be described by a simpliﬁed hierarchy
of elements of increasing length from primary structure
(sequence of single amino acid) over secondary structure ele-
ments (α-helices and β strands of ~10 residues) to tertiary
structure (folded domains of ~100 residues) and quaternary
structures (i.e. assemblies of several folded proteins). IDPs cannot
be as straightforwardly classiﬁed in a simple hierarchy of modules
of increasing length because the minimal unit, a single IDR, can
vary in length from a few residues to thousands of residues.
Accordingly, IDRs can vary signiﬁcantly in their properties and
functions and the need for further differentiation of sub-classes of
disorder was recognized early in the development of the ﬁeld15.
While the structure-function paradigm is fully established and
has been highly successful, a complementary disorder-function
paradigm is still emerging16.
Co-evolutionary inference suggests that many predicted
disordered regions have the capacity to fold and are selected in
evolution by contact constraints imposed by the folded con-
formation in the presence of cellular binding partners17. In
other words, such binding-coupled folding IDPs look similar to
folded proteins as determined by (co)evolution statistical ana-
lysis. Interfaces of foldable IDRs tend to be larger than contacts
between two ordered proteins and the exposed hydrophobic
surface area is often larger, which in some cases limits the
solubility of IDPs and requires tighter subcellular regulation of
IDPs compared to ordered proteins18–20.
One of the least characterized aspects in IDR research is in vivo
malleability leading to multiple structural forms that disordered
regions can adopt in a given compartment in a given cellular
state. According to in vitro experiments, it can be expected that
subtle variations in pH, salt concentrations, and PTMs can have
very signiﬁcant effects on the conformational ensembles of
IDPs21. For instance, nuclear pore proteins can form extremely
tight complexes (dissociation constant (Kd) in low pM range)
near physiological salt concentration (~100 mM) which becomes
very weak (Kd in mM range) at 200 mM salt concentration22.
Indeed, a large-scale multidimensional proteomics study that
investigated temperature-dependent solubility and abundance
changes across cell cycle phases, demonstrated that large subsets
of the human proteome dramatically change their solubility,
stability, subcellular organization and protein partners in patterns
resembling differential phosphorylation during the cell cycle23. A
more direct link between phosphorylation and stability changes
has been discovered using a recent method termed ‘hotspot
thermal proﬁling’ that combines thermal protein solubility and
subsequent phospho-enrichment to quantify how ‘phosphomo-
diforms’ differ in their melting properties. This study showed that
phosphorylation in loop regions induces the largest range of
changes in the melting points of their respective proteins24.
Early reports suggested that site identiﬁcation in phosphor-
ylation predictions can become signiﬁcantly more accurate if local
intrinsic disorder tendency is taken into consideration25. Many
single-protein examples illustrate that IDRs can be phosphory-
lated or hyper-phosphorylated within disordered residues, often
at highly soluble and intrinsic disorder-promoting serine and
threonine residues11,12,26–28. The correlations of IDRs with
acetylation, ubiquitination and sumoylation of lysine residues,
and phosphorylation events at residues such as tyrosine and
histidine are more challenging to detect, and hence are frequently
under-reported in scientiﬁc studies29–33. Finally, there are very
few studies reporting possible interactions between IDRs and
multiple types of PTMs.
Biotinylation-based proximity proteomics methods are tradi-
tionally used to map transient interactions and subcellular
neighbours34–38. The common principle of various proximity
proteomics approaches is that biotinylation is highest in the
vicinity of the biotin-activating enzyme that is fused to protein of
interest. Most proximity proteomics studies aim to quantify
biotinylated proteins in the vicinity of the biotin-activating
enzyme. Because no direct sites of biotinylation are obtained in
this approach, stringent statistical tests are required to remove
endogenously biotinylated and non-speciﬁc avidin-bead binding
proteins. Several recent technological improvements have enabled
the direct detection of thousands of biotin sites in hundreds of
proteins in a single study39–42. We, therefore, reasoned that these
novel large-scale in vivo biotin site data could be repurposed to
gain insights into possible cellular conformations of proteins.
The most frequently used enzymes in proximity proteomics are
variants of BirA biotin-protein ligase and ascorbate peroxidase
(APX)36,37,43,44. A promiscuous mutant of BirA (BioID) as well as a
thermophilic homologue (BioID2) biotinylate nearby lysine residues
through the formation of activated biotinoyl-5′-AMP which forms a
covalent attachment to the nucleophilic ε-amino side chain group of
lysine (K). APX or accelerated versions like APEX2 can convert
biotin-phenol to activated radicals that can readily react for a short
period of time with nearby tyrosine residues (Y). Interestingly, these
two amino acid types are on opposite ends of the disorder-
promoting amino acid scale—lysine promotes disorder while tyr-
osine is on average depleted in IDRs45.
Here, we hypothesize that proximity labelling studies can be
biased by structural features of target proteins and test this
hypothesis using large-scale datasets. We demonstrate the
enrichment of cellular biotinylation events in predicted IDRs of
proteins in HEK293 cells which points to the re-purposing of
in vivo biotinylation to achieve comprehensive conformational
proteomics studies in intact cells.
Results
Concept of the study. To gain insights into conformational
plasticity of predicted IDRs in vivo, we explored whether sub-
cellular biotinylation patterns can vary with the extent of pre-
dicted local ﬂexibility of proteins (Fig. 1a). We reasoned that
IDRs that remain unfolded and unconstrained by interactions
in vivo would be expected to be more readily biotinylated given
their large accessible surface and high dynamics22,46. Alter-
natively, IDRs that completely fold upon forming interactions
with other proteins47 should have average levels of biotinylation.
Furthermore, IDRs that are comprised of concatenated short
interaction motifs may simultaneously interact with multiple
partner proteins that limit tagging efﬁciency by shielding
interacting surfaces48.
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Selection of orthogonal large-scale proximity proteomics stu-
dies to test our hypothesis. To test our hypothesis of possible links
between structural features of proteins and biotinylation, we selec-
ted four recent, independent, large-scale in vivo biotinylation stu-
dies by the following criteria: large number of directly identiﬁed
biotinylation sites; orthogonality in targeted subcellular niches; and
independence of biotin-peptide enrichment strategies (Fig. 1b–e).
Firstly, the DiDBiT study of Schiapparelli et al. targeted the
whole cell and is therefore agnostic of subcellular localisation.
This study identiﬁed ~20,000 biotinylation sites on lysine sites
upon extensive biotinylation by applying 1 mM NHS-biotin, a
chemically activated form of biotin, to cultured HEK293 cells,
complete digestion by trypsin and streptavidin-afﬁnity puriﬁca-
tion of biotinylated peptides41. Secondly, the SpotBioID study of
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Fig. 1 Large-scale in vivo biotinylation datasets can be re-purposed to identify accessible protein regions in vivo. a Concept of the study. Predicted IDRs
are compared with in vivo biotinylation sites and the most frequently reported post-translational modiﬁcation sites to identify highly accessible regions in
proteins. Study design of re-analyzed studies: b DiDBiT41 c SpotBioID42 d BioSITe39 e AB-APEX240. f Tyrosine solvent accessible surface area (SASA) is
reduced signiﬁcantly (~90%50) in folded proteins as illustrated on the APX structure (PDB ID 1APX). g Lysine sidechains contribute a large fraction of the
total surface in typical folded proteins as illustrated in the Aquifex aeolicus BirA (BioID2) structure (PDB ID 3EFR). Some 50% of the average lysine’s SASA
stays exposed in folded proteins50.
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Lee et al. targeted rapamycin-dependent interactions of the
human mTOR kinase using its FK506-rapamycin binding (FRB)
domain fused to BioID42. Immunoﬂuorescence data within the
SpotBioID study conﬂicts with previous literature concerning the
main subcellular localisation of FRB-BioID fusion that appears to
be cytoplasmic in ﬂuorescence experiments and nuclear in
previous literature and biotin-protein enrichments42, with most
evidence suggesting a mainly nuclear localisation of the FRB-
BioID fusion. The remaining two datasets come from recent,
tyrosine-targeting APEX2 studies. Both successfully explored an
alternative enrichment strategy based on polyclonal biotin-
antibodies to achieve gentle elution while retaining explicit biotin
site information unlike other strategies involving gentle elution of
cleavable biotin derivatives39,40,49. They comprise an antibody-
based APEX2 study (within this paper termed Ab-APEX)
targeted the mitochondrial matrix using mito-APEX240, and a
study called BioSITe39 which uses a cytoplasmic APEX2 fusion
construct to Nestin (NES) protein
Orthogonality of tyrosine and lysine as molecular targets of
proximity proteomics. How different are tyrosine and lysine
residues, the most frequent molecular targets in proximity pro-
teomics? Tyrosine is a partly hydrophobic and bulky amino acid
and predominantly partitions to the hydrophobic core of proteins
and near the interface of intrinsic membrane proteins. Its solvent
accessible surface area (SASA) shrinks by some 90% during
folding reactions (Fig. 1f)50. Lysine residues, by contrast, tend to
orient to the surface of folded proteins and stay in contact with
surrounding water molecules, i.e. retain a large fraction of their
SASA (Fig. 1g). Nevertheless, through their intramolecular and
intermolecular contacts, for instance, in protein–protein inter-
actions, lysine residues have a large spectrum of accessibilities
with an average near 50% of remaining SASA in folded pro-
teins50. We reasoned that the orthogonality of these two amino
acids would be helpful to comprehensively test our hypothesis
that in vivo biotinylation can be signiﬁcantly favoured in
predicted IDRs.
Proximity proteomics studies can speciﬁcally target subcellular
locations. As expected, the four studies targeted different sub-
cellular niches and thus there was a very small overlap in proteins
across the four studies with only 29 proteins being in common
(Supplementary Fig. 1a). Of these 29, many of them had multiple
cellular locations predominating in the nucleus (Supplementary
Fig. 1b, blue), cytosol (Supplementary Fig. 1b, red) and the
extracellular region (Supplementary Fig. 1b, yellow). Given the
small size of this subset of the whole dataset, these locations were
not statistically enriched despite being frequently seen. However,
we could conﬁrm the location for each of the studies above (n >
500) using a functional enrichment analysis against a set of gene
ontology (GO) terms aimed at describing cellular location (GO:
CC; Supplementary Fig. 1c). Our data analysis show that as
expected, Ab-APEX proteins strongly target the mitochondrion
with high fold enrichment for the mitochondrial matrix and the
mitochondrial inner membrane (Supplementary Fig. 1c, ﬁrst
column). We then interrogated the BioSITe data which also as
presumed based on the NES-APEX fusion, was enriched in GO
terms of the cytoplasm and the cytosol (Supplementary Fig. 1c,
second column). The DiDBiT study, which lacks speciﬁc targets
appeared to be enriched for nuclear, mitochondrial and cytosolic
proteins (Supplementary Fig. 1c, column 3). Finally, data from
the SpotBioID study, where the authors state that FRB-BioID is
cytoplasmic, were enriched for mostly nuclear and some cytos-
keletal proteins42.
We also explored the overlap in the subcellular assignment for
these repeatedly identiﬁed proteins according to previous large-
scale studies. We tested the consensus of assignments among
efforts to map the subcellular distribution of proteins in the
primarily immunoﬂuorescence-based subcellular Human Pro-
teome Atlas (HPA) study51, a recent mass spectrometry-based
‘Localisation of Organelle Proteins by Isotope Tagging after
Differential ultracentrifugation’ (LOPIT-DC) study52 as well as
the Uniprot database53. This analysis revealed that out of all
repeatedly identiﬁed proteins across the four studies only one,
namely the well-characterised endogenously biotinylated pyru-
vate carboxylase, showed a unique consensus location in the
mitochondrion (Supplementary Data ﬁle 2). Given the different
resolution of these different sources of subcellular location
information, we also analysed if there is a partial consensus, for
instance within different parts of the nucleus. We identiﬁed two
examples of proteins that share a partial consensus location in the
nucleus. Both proteins (Heterogeneous nuclear ribonucleoprotein
M and TATA-binding protein-associated factor 2N) are predicted
>70% disordered and share multiple sites of biotinylation across
studies with the same target amino acid (Supplementary Data
ﬁle 2). We also examined the patterns of biotinylation in the
endogenously biotinylated mitochondrial pyruvate carboxylase.
As can be reasonably expected, this enzyme showed more sites of
biotinylation in the Ab-APEX study than in other studies that did
not target the mitochondrion (Supplementary Data ﬁle 2). Brieﬂy,
all studies except SpotBioID showed expected enrichments
consistent with the targeted cellular compartment and most
previous literature.
Illustrative examples of proteins that are biotinylated across all
four independent studies. We next explored the structural fea-
tures of the limited subset of 29 proteins that were common in all
studies by combining all biotinylation sites in the four datasets.
While not statistically signiﬁcant, we noticed that the list con-
tained many RNA binding proteins. Elevated IDR content among
these proteins is consistent with previous reports of high IDR
content among nucleotide-binding proteins54 but a larger set will
have to be explored for ﬁrmly establish a statistical correlation.
The ﬁrst example, Emerin, is an integral membrane protein that is
often found at the inner nuclear membrane or at adherens
junctions. Emerin mutations cause X-linked recessive
Emery–Dreifuss muscular dystrophy. Biotinylation sites from all
four studies cluster in a large predicted IDR in the ﬁrst half of the
protein sequence, avoid the transmembrane-spanning domain
(Fig. 2a–e) consistent with our hypothesis that predicted IDRs
might be more biotinylated in vivo if they remain highly acces-
sible. A very large number of other PTMs in this IDR further
illustrates that this membrane protein is indeed often subjected to
intracellular modiﬁcations (Fig. 2a, Supplementary Data ﬁle 1,
BioPTM-IDR-correlation). Surprisingly, Emerin is found in all
four studies despite the fact that some targeted different sub-
cellular locations.
Emerin is the only integral membrane proteins that was
repeatedly identiﬁed across all studies. An additional ~400
integral membrane proteins are identiﬁed in at least one of the
four studies suggesting that detailed intracellular structural
insights can be gleaned from re-purposed proximity proteomics
studies.
Next, we analysed the predicted fully disordered RNA-
interacting plasminogen activator inhibitor protein SERBP1
(Fig. 2f). Four sites of biotinylation, across the four studies,
cluster around the central region of this protein (residues
200–260) where previously reported unique PTM sites also
cluster (Fig. 2g). DiDBiT identiﬁes many additional sites scattered
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over the entire protein sequence, ﬁve of which are common with
the nuclear targeted SpotBioID study. SERBP1 was previously
found in multiple subcellular locations consistent with its
identiﬁcation in four studies. SERBP1 has a solved structure in
which it is attaching at the periphery of the 80S ribosome
RNA–protein complex and mostly lacks (throughout ~80% of its
sequence) unique electron density (Fig. 2h); remaining small
visible fractions form elongated structures that are detected in
random coil or α-helical conformations. This SERB1 example
provides anecdotal evidence that disordered regions can be
densely biotinylated.
Finally, we selected FK506- and rapamycin-binding protein
(FKBP3) as a protein of average (predicted) disorder content for
the human proteome around 40% according to VSL2b2. FKBP3 is
a cis-trans prolyl isomerase that is involved in cellular protein
folding and tightly binds to the immunosuppressant rapamycin.
We noted that biotinylation events were enriched in its predicted
IDRs (72% of sites of biotinylation are within IDRs) or localised
to local coil structure and short, highly accessible α-helical
segments in the NMR structure (Fig. 2i).
We conclude that detailed inspection of common examples
across four studies suggests an enrichment of biotinylations in
IDRs and regions lacking deﬁned secondary structure in
otherwise folded proteins. Furthermore, the observed differences
in biotinylation sites between studies is likely due to multi-
localised proteins changing conformation and/or protein–protein
interactions in different subcellular niches.
Predicted IDRs are more frequently and densely biotinylated
in vivo. Encouraged by our observations that biotinylation events
were enriched within the predicted IDRs in the small pool of
proteins common to all four studies, we next considered whether
this trend might still hold globally for the biotinylated proteome
(referred to as biotinome hereafter) comprising nearly 4000
proteins. We ﬁrst checked if proteins with higher predicted
fraction of IDRs contain higher numbers of unique sites of bio-
tinylation by comparing the predicted IDR fraction for proteins
in each biotinome to the number of biotinylated sites they con-
tained (Fig. 3a). Within each dataset, there were only a small
number of proteins with ﬁve or more biotinylation sites and
hence these have been collectively binned into the 5+ category
(Fig. 3a, most right hand violin). For both the SpotBioID and the
BioSITe studies, we observed an increase in the frequency of sites
of in vivo biotinylations per protein from 1 to 4 with increasing
IDR fractions, while DiDBiT and Ab-APEX did not show this
trend (Fig. 3a). Both the cytosol and the nucleus, which are target
compartments in BioSITe and SpotBioID have been previously
suggested to contain many IDRs54. Mitochondria, by contrast, are
predicted low in IDRs especially their subset of proteins with
bacterial homologues55. The DiDBiT study, lacking compart-
mental preference, contains both highly disordered and fully
folded proteins which might mask any possible weak correlation.
Alternatively, it is possible that the long exposure of cells to very
high concentrations of activated biotin in the DiDBiT study can
saturate the less accessible and mostly folded regions in proteins.
This may result from dynamic folding states of such proteins over
time that are not captured with shorter labelling times and the
limited concentrations of activated biotin in the vicinity of
APEX2 or BirA variants in typical proximity studies. We con-
cluded that in vivo observed biotinylation frequency per protein
and predicted IDR fractions can be correlated in IDR-rich com-
partments such as the nucleus and cytosol in HEK293 cells
(Supplementary Data ﬁle 1, Biotin-list).
To overcome limitations of averaging over IDRs and ordered
regions that might have masked structural trends in the DiDBiT
and Ab-APEX studies, we next reﬁned our analysis by
distinguishing between biotinylation events inside and outside
of IDRs while accounting for the density of potentially modiﬁable
residues. To establish an expected rate of biotins, we calculated
the number of lysine residues (K; for SpotBioID and DiDBiT) or
tyrosine residues (Y; Ab-APEX and BioSITe)—both within the
predicted regions of IDR (as determined by VSL2b) and across
the entire protein body. The ratio of all K/Y residues within IDR
regions to all K/Y residues across the protein body gave us an
expected rate of biotinylation in IDRs. We then performed a
similar calculation using the numbers of biotins we actually
observed within IDRs and across the whole protein for each of
our 4 studies (Fig. 3b). Other than in the DiDBIT study, we
observed a signiﬁcantly greater number of biotins within IDR
regions (orange bars; Fig. 3b) than expected (blue bars; Fig. 3b) by
one or more prediction algorithms. This observation was more
signiﬁcant in the cytoplasmic (BioSITe) and nuclear proteins
(SpotBioID) than in the mitochondrial proteins (Ab-APEX)
(Supplementary Fig. 2a).
Convinced that we are seeing a true positive correlation in
three out of four studies, between local predicted IDRs and
biotinylation density, we next sought to see if similar trends can
also be observed on protein level after sorting all proteins in
classes ranging from most to least folded. To this end, we labelled
a protein as Folded (F) if it had predictions of <10% IDR, Partially
Folded (P) if it had 10–30% IDR and Unfolded (U) if it had >30%
IDR in its protein body similar to a strategy in Gsponer et al.19.
We then looked at the overall distribution of proteins in these
IDR classes for each of our 4 studies (Fig. 3c) where we display
the results for just VSL2b and IUPred-L algorithms as
VSL2b_IUPred-L mimics the trend of VSL2b alone while the
D2P2 consensus mimics IUPred-L. We observed that all studies
contain proteins that can be classiﬁed as F, P and U thus enabling
pairwise comparisons. The predictors that are better at predicting
long IDRs or the absence of folded domains, IUPred-L and D2P2
consensus predictors56,57, classiﬁed more proteins as F than
VSL2b that has a wider deﬁnition of IDRs that also includes short
IDRs. Consistent with our previous observations and claims in
literature22,54, the nuclear protein enriched SpotBioID dataset
shows the highest proportion of U proteins while the mitochon-
dria targeting Ab-APEX study shows the highest proportion of F
proteins (Fig. 3c, Supplementary Figs. 2b, 3).
Given these three categories of proteins, we wondered whether
there would be an association between IDR-associated-biotins
and the various categories of IDPs. To assess this, we performed
both pairwise t-tests between the groups (F-P, U-P, U-F;
Supplementary Fig. 2c) and an ANOVA across all groups
followed by a Tukey’s Honestly Signiﬁcant Differences post-hoc
test (Supplementary Fig. 2d). In all studies except the SpotBioID
study, there were signiﬁcant differences between biotin numbers
in the F and U group with more biotinylation events occurring in
the U group. Additionally, the differences were signiﬁcant for all
studies between U and P groups, once again showing higher
number of biotins in the U group (Fig. 3d; Supplementary
Fig. 2c).
To investigate whether larger structured complexes can also be
analysed with biotin ‘painting’, we ﬁltered the DiDBiT dataset for
ribosomal proteins and visualised all biotinylated subunits in an
exploded version of the 80S ribosome (Fig. 4 and Supplementary
Fig. 4). Virtually all biotinylated subunits are non-globular and
contain many biotinylations. Many of these are inaccessible to
water or larger molecules such as biotin in the fully assembled 80S
ribosomal complex as they are contacting ribosomal RNA
(Supplementary video 1). High biotinylation density in the 80S
ribosome is consistent with an earlier suggestion that eukaryotic
ribosomes are rich in predicted IDRs that can be functionally
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Fig. 3 Predicted IDRs are preferentially in vivo biotinylated across all studies a Violin plots (i.e. mirrored density distribution plots) showing the relationship
between number of biotins and length of IDR across all biotinylated proteins. Biotin numbers >= 5 are grouped into one set to show the general trend of
the data. The red line in the middle of each violin represents the median fraction of IDR for that group. b Barplots showing the Expected (pale blue) and
Observed (pale orange) distribution of biotins within regions of IDR across the 4 studies using the IDR caller VSL2b (Top) and IUPred-L (bottom).
Signiﬁcance: ***p < 0.0005; ****p close to 0, using a binomial test where the “probability of success” is the (number of lysine residues or tyrosine residues
in IDRs/Total number of lysine residues or tyrosine residues), a “success” is a biotin within an IDR and “number of trials” is the number of biotins observed
in that study. c Barplots showing the distribution of proteins from the four studies across the three structural classes19: Folded (F, 0–10% disorder; purple);
Partially Folded (P, 10–30% disorder; Yellow) and Unfolded (U, >30% disorder; orange) for two different IDR callers VSL2b (Top) and IUPRed-L (bottom).
The numbers of proteins in the VSL2b caller are displayed in Supplementary Fig. 2b. We note that disorder classiﬁcations vary substantially with speciﬁc
predictors, which is expected given their differences in precision and recall. At least for SpotBioID, all tested prediction tools indicate that most sites of
biotinylation map to partially folded or unfolded proteins. d Bean-plots58 showing the distribution of biotins that occur within VSL2b predicted IDRs across
the 3 classes F, P, U in each study. The y-axis in on a log2 scale with values 0 and above representing 1 or more biotins. The red dotted line represents 0
biotins (with added correction factor). The solid black line in the middle of each violin represents the mean biotins (on log2 scale) for that group. The black
dotted line represents the mean log2(Biotins) across all groups.
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Fig. 4 Sites of in vivo biotinylations mapped on in silico disassembled 80S ribosome (PDB: 6EK0). An exploded ribosome plot showing the individual
proteins that make up the eukaryotic 80S ribosome with added biotinylation marks (bright yellow) from four biotinylation datasets. We can see that nearly
all ribosomal proteins have some yellow “paint” on them.
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-0758-y
8 COMMUNICATIONS BIOLOGY |            (2020) 3:38 | https://doi.org/10.1038/s42003-020-0758-y | www.nature.com/commsbio
essential. Additionally, it could indicate that elongated shapes of
ribosomal proteins that show unusually large interfaces are likely
to have low intrinsic stabilities upon dissociation from partner
proteins and ribosomal RNA58,59. Our statistical tests indicated
signiﬁcant enrichment of biotinylation density in ribosomal IDRs
beyond trivially expected modiﬁcation levels based on the
number of available residues that can be modiﬁed by activated
biotin (Supplementary Data ﬁle 1, Ribo-stats). We also extended
this analysis to the mitoribosome and found a similar enrichment
of biotinylation in IDRs of the mitoribosome (Supplementary
Data ﬁle 1, Ribo-stats). We observed frequent colocalization of
sites of biotinylation in vivo and high B-factors as measure of
local mobility according to high-resolution structural cryo-EM
analysis in vitro (PDB: 3j9m60, Supplementary Fig. 5).
Limited biotin painting maps to mobile regions within the
bacterial ribosome. To test empirically how fast both unstruc-
tured and structured regions in ribosomes can be biotinylated, we
performed a multiplexed proteomics experiment that explored
the time-dependence of biotinylation in puriﬁed 70S ribosomes
from E. coli. We labelled puriﬁed 70S ribosomal complexes using
1 mM NHS-biotin for either 10 s, 120 s or 300 s and subsequently
labelled these peptides with different TMT tags to quantify the
relative intensity of biotinylation in these different timepoints for
all detectable sites of biotinylation. We observed the highest
preference for disordered regions at short labelling times (10 s)
and deeper structural penetration after ﬁve minutes of labelling
(Supplementary Fig. 6, Supplementary Fig. 7, Supplementary
Data ﬁle 3). Clearly, biotin painting was more limited to highly
exposed and disordered regions at limiting times of incubation
with activated biotin.
Discussion
We describe here the ﬁrst in vivo evidence for preferential bio-
tinylation of predicted IDRs in four independent proximity
proteomics studies, to our knowledge. This observation adds a
new type of (exogenous) tag to a list of naturally occurring PTMs
(phosphorylation, sumoylation) that have previously been sug-
gested to be enriched in IDRs25,33 and which we have further
conﬁrmed within this dataset (Supplementary Data ﬁle 1, Sup-
plementary Fig. 8). This raises an important question as to
whether proteins ﬁrst unfold in vivo before modiﬁcation or
unfold after modiﬁcations. It will be interesting to comprehen-
sively explore the proteome-wide interplay between structure and
the rate of addition and removal of speciﬁc PTMs. Similar to
Hotspot Thermal Proﬁling24, which compares thermal solubility
of proteomes and their phosphorylated complement to detect the
impact of phosphorylation on thermal stability of speciﬁc pro-
teins, biotin painting might be combined with enrichment of
speciﬁc PTMs to probe the local structural impact of these PTMs.
If speciﬁc PTMs favour local unfolding, one would expect more
biotinylation in their vicinity upon enrichment. Alternatively,
some PTMs might induce local folding or enhance binding afﬁ-
nity with partner proteins and thereby limit local accessibility.
Biotin painting shows promise to provide new global insights into
PTM-induced structural rewiring in cells.
Ribosomal proteins piqued our particular interest both because
of their high cellular abundance and because they help to accel-
erate the most diverse biosynthesis of nearly all polypeptides and
proteins, which requires exceptional ﬂexibility and functional
plasticity. We observed that many of ribosomal proteins had
biotinylation marks in regions that are covered by RNA in
structural snapshots of the 80S particle (Fig. 4 and Supplementary
Fig. 4). Based on our observation that many of these biotinyla-
tions occur in solvent-occluded regions, we reasoned that biotin
‘painting’ is likely to happen during the intermediate steps of
ribosome assembly during which otherwise hidden lysine and
tyrosine residues would be exposed or during reversible dis-
sociation of individual ribosomal proteins that can interact with
the small (18S) or large (28S) ribosomal RNA hubs (Supple-
mentary Fig. 4). Alternatively, it is also possible that biotinylation
occurs on nascent chains of ribosomal proteins as they emerging
from translating ribosomes. The fact that we observe a statistical
enrichment of sites of biotinylation within IDRs in ribosomal
proteins suggests that promiscuous biotinylation of nascent
chains outside of IDRs is infrequent (Supplementary Data ﬁle 1).
Several endogenous PTMs of ribosomal subunits, including
acetylation, phosphorylation and methylation have recently been
identiﬁed and further support the notion that the large surface of
ribosomal proteins (Fig. 4 and Supplementary Fig. 4) can be used
for efﬁcient post-translational modiﬁcations (Supplementary
Data ﬁle 1)61. Brieﬂy, we observed extensive biotinylation in
ribosomes, mostly in their IDRs, consistent with expected high
ﬂexibility of ribosomes and previously observed dense modiﬁca-
tion with multiple types of other PTMs.
We envisage many possible beneﬁts from our novel biotin
painting assay concept for exploring in vivo structure-functional
questions; Firstly, to complement very detailed kinetic in vitro
studies that can resolve conformational dynamics at high spatial
and temporal resolution using hydrogen deuterium exchange
(HDX). Biotin painting could enable complementary in vivo
comparisons of the same target proteins and thereby increase the
scope of HDX or related protein surface accessibility-based
structural proteomics techniques62–64. Secondly, to acquire
dynamic snapshots of biological pathways and determine by
which mechanism these rewire biomolecular interaction networks
and modulate subcellular conformations of proteins as recent
technological advances both in biotinylation enzymes and mul-
tiplexed mass analysis will accelerate sampling of more biological
timepoints65–67. Thirdly, to study dynamic in vivo drug effects.
Many new drug candidates are failing in the later stages of
development due to our incomplete understanding of cellular
biology. If we can re-purpose BioID or other biotinylation
methods for elucidating subcellular protein interactions, we might
achieve earlier insights into drug (in)efﬁciency in relevant bio-
logical contexts.
Our analyses were enabled by the precise identiﬁcation of sites
of biotinylation using peptide-level enrichment which are not
typically captured in more widely used protein-level experiments.
An obvious limitation of peptide-level enrichment is that non-
biotinylated peptides cannot contribute to the mass spectrometric
signal, which can mean that more biological input material may
be required in some cases. While peptide-level enrichment
increases the speciﬁcity and analytical efﬁciency for detecting
biotinylated peptides39–42, it comes at the expense of not being
able to detect proteins that lack lysines or detectable peptides with
one missed cleavage (due to a modiﬁed lysine). Sequence cover-
age might be improved by including additional proteases in future
biotin-based proximity experiments68.
A key assumption in classical proximity proteomics studies is
that biotinylation is enhanced near the biotin-activating enzyme.
Our study shows that unfolded regions can be more readily
biotinylated compared to folded regions. This could mean that
proteins that in reality never change their cellular distribution can
be perceived as spatially further away or closer to a BirA-fusion
due to condition-dependent local folding or unfolding, respec-
tively. We do not currently have deﬁnitive answers on how to
unambiguously dissect condition-dependent local (un)folding
from subcellular redistributions. It appears worthwhile to envi-
sage the possibility that transient changes in protein folding can
be important modulators of cellular dynamics that should be
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more broadly factored into experimental designs of proteomics
studies (Fig. 5).
In summary, we have shown using several orthogonal analyses
that in vivo biotinylation occurs at a greater rate within predicted
IDRs and that highly disordered proteins are more likely to be
biotinylated than those that are mostly folded. Furthermore, this
trend of increased biotinylation in IDRs is not dependent on the
algorithm we use to predict IDRs. However, the greater sensitivity
of VSL2b enables the establishment of the trend also in short
regions of local disorder and leads to a greater IDR fraction and
more biotinylations assigned to IDRs. Finally, we have con-
sistently observed that the SpotBioID study has more proteins
that are highly disordered than the other three studies thereby
validating previous predictions of large fractions of IDRs in
nuclear proteins in vivo54.
We envisage the possibility to repurpose cellular biotin tagging
experiments to complement existing structural biology tools such
as HDX-MS and provide fundamentally new insights into the
cellular context of protein dynamics and interactions.
Methods
Source data description. Four independent in vivo biotinylation studies have been
used for our exploration of structural speciﬁcity of biotinylation sites. Their details
are provided in Table 1 and they can be accessed as input ﬁles on the Github
repository https://github.com/ComputationalProteomicsUnit/biotinIDR.
Experimental input data to develop IDR predictions. Some 60 published dis-
order prediction algorithms feature balanced accuracies of around 70–80%; some
being designed and validated to predict short IDRs (<30 residues) and others being
better at determining long or both long and short IDRs69. The majority of these
predictors are trained on a limited set of in vitro structural data, mainly X-ray
crystallography data, Nuclear Magnetic Resonance (NMR) mobility data in the
DisProt database (http://www.disprot.org/)70.
D2P2 resource description and selection of predictions. A subset of more
frequently used prediction algorithms has pre-computed predictions in the web
resource D2P2 (http://d2p2.pro/56). D2P2 also offers the option to select a con-
sensus call for IDRs in a given protein that is predicted by most of the nine
different compound predictors. Of the nine callers included in D2P2, we focused
our interest initially on the two most orthogonal callers: VSL2b which has high
sensitivity for calling IDRs in both short and long regions of IDR71 and IUPRed-L
which has been trained to predict long disorders with high conﬁdence57. As
additional comparisons, we also predicted IDRs using a combination of VSL2b and
IUPRed-L where an IDR was accepted if called by one or both predictors and
consensus of (at least 75% of) nine predictors included in D2P2 (Supplementary
Fig. 3).
Assigning disorder predictions. For all versions of IDR calling, we did not set any
restrictions on the length of IDR. This means that an IDR can be called on a
residue of length 1. While this might yield a lot of false positives, we wanted to
ensure sensitivity rather than speciﬁcity of IDR calling. Having tested the four
different versions of IDR calling with D2P2, we realised consistent trends between
all predictions approaches while higher local sensitivity of VSL2b enabled more
insights on local disorder. We, therefore, performed more detailed biotin site and
PTM analyses using VSL2b. The IDR assignment uses an Application Program-
ming Interface (API) to the D2P2 website and code to use this API was kindly
provided by Dr. Tom Smith. The scripts d2p2.py and protinfo.py are necessary for
the ﬁnal analysis and can be accessed through the github repository https://github.
com/TomSmithCGAT/CamProt/tree/master/camprot/proteomics. The python
script for the ﬁnal IDR analysis and output is called Get_IDRs-DM-v2.py and can
be accessed via the repository https://github.com/ComputationalProteomicsUnit/
biotinIDR.
Biotins
Disordered region
Activated biotin
Folded protein
in silico predicted in vivo observed
Folded
Fig. 5 Biotin tagging favours unfolded protein regions in cells. Biotinylation are more likely in predicted IDRs suggesting that they are more (at least
transiently) accessible for biochemical modiﬁcations compared to folded proteins. Fully folded proteins can also be modiﬁed but show lower fractions of
modiﬁed residues compared to IDRs. This positive correlation of biotinylation density and IDRs, i.e. biotin painting IDRs can be used to re-purpose
biotinylation-based proximity proteomics studies to monitor protein plasticity in vivo.
Table 1 Sources of data used in this study, Supplementary Information (SI).
Study Ref Target Chemistry Data Source Concentration of activated biotin [μM]
BioSITe 39 Tyrosine APEX2 SI ﬁle 2, Supplementary Table 8 <50
Ab-APEX 40 Tyrosine APEX2 SI Table 6 <500
DiDBiT 41 Lysine NHS-Biotin SI ﬁle 2, Table S27 1000
SpotBioID 42 Lysine BirA SI ﬁle 2, sheets 2–5 <50
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Protein sequence modiﬁcation or proteoform images. Images summarising the
location of IDRs and PTMs were produced using Protter (http://wlab.ethz.ch/protter/
) and protein structure images were generated using Pymol. For Protter images,
scripts were written to generate an appropriate URL and then batch download it
from the server. These scripts printUrl.py and runUrl.sh are also available via the
Github repository https://github.com/ComputationalProteomicsUnit/biotinIDR
(Supplementary Data 1, Protter-List).
Statistical tests used. To compare expected rates of biotin/PTMs and observed
counts, we used a standard binomial test in R (binom.test). For estimating the
background rate of biotins, we counted all the lysines (K; BirA based studies) or
tyrosines (Y; APX based studies) in the protein sequence and within predicted
IDR regions. For estimating the background rate of PTMs, we counted all the
lysines (K; ubiquitination, acetylation, sumoylation) or serines, threonines and
tyrosines (S, T, Y; phosphorylation) in the protein sequence and within pre-
dicted IDR regions. We deﬁned the probability of success as the number of
residues in IDRs/Total number of residues, a success as a biotin or PTM within
an IDR and number of trials is the number of Biotins or PTMs observed in
that study.
We applied a similar test to the one above look for enrichment of biotins
speciﬁcally in ribosomal proteins, separated by cytosolic ribosomal proteins and
mitochondrial ribosomal proteins using their protein names.
To look for differences in PTMs and biotins in the three protein groups—
Folded, Partially Folded and Unfolded, we used pairwise t-tests or ANOVA
followed by a post-hoc correction of family-wise error rates using a Tukey’s
Honestly Signiﬁcant Differences test. The former yields a p-value while the latter
yields a conﬁdence interval for the effect size as well as a p-value. To compare
number of biotins and IDRs, we used a standard Pearson’s correlation test. To
compare mean PTMs between the HEK293 biotinome and HEK293 proteome we
used a standard t-test for means.
To perform a GO enrichment analysis, we used the package goseq72 which is
based on a Hypergeometric test with a Wallenius’ correction which accounts for
any biases in the data such as gene length, protein expression etc. In our study, we
used protein expression from Geiger et al.73, as the bias factor prior to calculating
GO enrichment.
Biomolecular structure visualisation. The Cryo-EM structure of the human 80S
ribosome (PDB ID 4v6x74) was visualised using ChimeraX75. SERBP1 and its
biotinylated sites were highlighted using the sel function in its command line
interface. RNA was coloured purple and protein subunits (except SERBP1) blue.
All ribosomal macromolecules were visualised in surface representation. The
FK506- and rapamycin-binding protein 3 (FKBP3) NMR structure (PDB ID 2mph)
was visualised in cartoon model of the ﬁrst low energy model; surfaces were kept
90% transparent except around biotinylation sites that were highlighted in yellow.
Bacterial 70S ribosomes were visualised using white for proteins and pale turquois
for nucleic acids and red for sites of biotinylation.
Bacterial 70S ribosome puriﬁcation. Strain JE2876 was grown in 2 x YT media
with 50 μg/ml kanamycin in bafﬂed ﬂasks at 37 °C to OD600 nm of 1.0 and harvested
by centrifugation and resuspended in ‘High Mg2+ buffer A’ (50 mM HEPES pH
7.0; 20 mM MgCl2; 50 mM NaCl; 50 mM KCl; 100 mM NH4Cl; 5% glycerol; 1
tablet per 250 mL of cOmplete protease inhibitor cocktail tablet (Roche). Cells were
ﬂash frozen with liquid nitrogen and stored at −80 °C. A thawed cell suspension
was lysed with emulsiﬂex at 15,000 psi and clariﬁed by centrifugation at 32,000 × g
for 30 min at 5 °C.
For 70S, the lysate was applied to HiTrap chelating resin with bound Ni 2+
in high Mg2+ buffer and eluted with gradient 0–100% ‘High Mg2+ buffer B’
(50 mM HEPES pH 7.0; 20 mMMgCl2; 50 mM NaCl; 50 mM KCl; 100 mM NH4Cl;
5% glycerol; 1 tablet per 250 mL of cOmplete protease inhibitor cocktail; 0.5 M
imidazole, adjust pH to 7.0).
The 70S particles were concentrated and applied to a preparative S200 column
(S200 buffer: 50 mM HEPES pH 7.0; 20mM MgCl2; 75mM KCl; 75mM NaCl; 5%
glycerol). While the matrix was not optimal for removing higher MW contaminants,
it was effective to remove contaminants smaller than the 30S, 50S and 70S.
Biotin painting the bacterial 70S ribosome. To test fast and slow biotinylation,
70S ribosomes were incubated with 1 mM NHS-biotin in triplicates for 10 s, 120 s,
300 s and 1 h. The 1 h timepoint was used as a carrier reference and excluded from
statistical analyses. The incubation took place at 37 °C in a buffer containing
20 mMMgCl2 (and 50 mM HEPES pH 7.0; 75 mM KCl; 75 mM NaCl; 5% glycerol)
and then quenched using 60 mM hydroxylamine for 15 min. Biotinylated ribo-
somes were heated to 95 °C for 10 min in 6M guanidine hydrochloride, 5 mM
TCEP, 10 mM Chloracetamide to denature proteins and alkylate cysteine residues.
Contaminants and biotin were removed using the modiﬁed SP3 protocol, brieﬂy by
precipitation using 20:1 (v/v) ethanol to peptide-bead mix and three subsequent
washes using 50 bead volume equivalents of 80% ethanol washing off the magnetic
beads as previously reported77. Samples were digested overnight at 37 °C with
1.2 µg modiﬁed trypsin-LysC (Promega). TMT labelling was performed directly on
beads using 60 μg per sample and channel using 10-plex (Thermo Fisher Scientiﬁc)
using a sufﬁcient molar excess of TMT label in HEPES buffer as previously
described78.
Mass spectra were acquired in positive ion mode applying data acquisition
using synchronous precursor selection MS3 (SPS-MS3) acquisition mode as in
Queiroz et al.79,80. Samples were analyzed in an Orbitrap Fusion Lumos (Thermo
Fisher Scientiﬁc), coupled to a 50 cm long PepMap nanoLC column (on a Dionex
Ultimate 3000 UHPLC). All samples were analyzed in a 120-min gradient from
9–45% buffer B (containing 80% acetonitrile) and SPS-MS3.
MS spectra processing and peptide and protein identiﬁcation. Raw data were
processed using Proteome Discoverer v2.3 (Thermo Fisher Scientiﬁc). The raw
ﬁles were submitted to a database search using Proteome Discoverer with
Mascot and SequestHF algorithms against the E. coli database downloaded in
early 2017, UniProt/TrEMBL. Common contaminant proteins (several types of
human keratins, BSA and porcine trypsin) were added to the database, and all
contaminant proteins identiﬁed were removed from the result lists before further
analysis. The spectra identiﬁcation was performed with the following para-
meters: MS accuracy, 10 p.p.m.; MS/MS accuracy of 0.05 Da for spectra acquired
in Orbitrap analyzer and 0.5 Da for spectra acquired in Ion Trap analyzer; up
to two missed cleavage sites allowed; carbamidomethylation of cysteine (as well
as TMT6plex tagging of lysine and peptide N terminus for TMT labelled sam-
ples) as a ﬁxed modiﬁcation; and oxidation of methionine and deamidated
asparagine and glutamine as variable modiﬁcations. Percolator node was used
for false discovery rate estimation and only rank 1 peptide identiﬁcations of high
conﬁdence (FDR < 1%) were accepted. TMT reporter values were assessed
through Proteome Discoverer v2.3 using the Most Conﬁdent Centroid method
for peak integration and integration tolerance of 20 p.p.m. Reporter ion inten-
sities were adjusted to correct for the isotopic impurities of the different TMT
reagents (according to the manufacturer speciﬁcations for the respective batch
number).
TMT data analysis. The data obtained from Proteome discoverer was abundance
data at the peptide level. We ﬁltered the data to remove missing values and any
non-biotinylationed peptides as well as peptides that were non-ribosomal. The data
were not median-normalised before the statistical analysis because we did not want
to introduce normalization artifacts by (artiﬁcially) equalizing actually very dif-
ferent fractions of biotinylated peptides within the total peptide pools in TMT
channels corresponding to 10 s and 300 s in our 10-plex TMT set (note: such a
normalization would make sense after speciﬁc enrichment for biotinylated
peptides).
We used the R81 package limma82 to test the signiﬁcant increase of labelling
between triplicate measurements at 10 s and triplicate measurements at either
120 s or at 300 s. TMT reporter ion intensities of biotin-peptides at 10 s were
used as reference and any signiﬁcant increases (using adjusted p-values smaller
than 0.05) were selected as ‘late’ biotinylation events while those that did not
statistically increase further after the 10 s timepoint were designated as early
biotinylation events and used for mapping of biotinylated sites within the 70S
cryoEM structure.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All TMT-multiplexed mass spectrometry data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository83 with the dataset
identiﬁer PXD016422. Details for the structural mapping of sites of biotinylation are
described in the Supplementary Dataset 3 and Supplementary Figs. 6 and 7.
Code availability
Code to process biotinylation datasets and reproduce the analysis has been deposited in
the Github repository https://github.com/ComputationalProteomicsUnit/biotinIDR.
Please request access to the code by emailing the corresponding authors as it will be made
public following journal acceptance.
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